The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers

The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers

Systemic therapy is one of the most significant cancer treatments. However, drug resistance often appears and has become the primary cause of cancer therapy failure. Regulation of drug target, drug metabolism and drug efflux, cell death escape (apoptosis, autophagy, et al.), epigenetic changes, and...

Full description

Bibliographic Details
Main Authors: Xun Zhang, Mingpeng Luo, Jiahang Zhang, Bize Guo, Shreya Singh, Xixi Lin, Hanchu Xiong, Siwei Ju, Linbo Wang, Yulu Zhou, Jichun Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Genetics
Subjects:
lncRNA H19
drug resistance
tumorigenesis
miRNA
chemotherapy
endocrine therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.1005522/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.1005522/full

Similar Items